- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
February 25, 2020
Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma.
February 25, 2020
A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma.
February 25, 2020
Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.
February 24, 2020
MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer.
February 24, 2020
A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma.
February 24, 2020
Toxicity Management of Front-Line Pembrolizumab Combined With Axitinib in Clear Cell Metastatic Renal Cell Carcinoma: A Case Study Approach.
February 21, 2020
miR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC).
February 20, 2020
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs.
February 20, 2020
Current State of Systemic Therapies for Advanced Renal Cell Carcinoma.
February 19, 2020
Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells.
February 19, 2020
Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma.
February 19, 2020
Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma.
February 18, 2020